Concepedia

Colin B. Erdman

CB

Statistics

Publications

2

Citations

290

H-Index

2

Active since

2014

Affiliations

Columbia University(Current)

BioVentures (United States)

Colin B. Erdman is an author at Columbia University specializing in post-marketing drug safety surveillance, adverse drug event reporting, and post-marketing safety surveillance.

Publications per year

2014–2014

2

Publications

2

The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010

Keith B. Hoffman, Mo Dimbil, Colin B. Erdman et al. · Drug Safety · 2014 · 180 citations · Full text

, , +16

Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS)

Keith B. Hoffman, A. Demakas, Mo Dimbil et al. · Drug Safety · 2014 · 110 citations · Full text

, , +16

1–2 of 2